<code id='DE28ED17E3'></code><style id='DE28ED17E3'></style>
    • <acronym id='DE28ED17E3'></acronym>
      <center id='DE28ED17E3'><center id='DE28ED17E3'><tfoot id='DE28ED17E3'></tfoot></center><abbr id='DE28ED17E3'><dir id='DE28ED17E3'><tfoot id='DE28ED17E3'></tfoot><noframes id='DE28ED17E3'>

    • <optgroup id='DE28ED17E3'><strike id='DE28ED17E3'><sup id='DE28ED17E3'></sup></strike><code id='DE28ED17E3'></code></optgroup>
        1. <b id='DE28ED17E3'><label id='DE28ED17E3'><select id='DE28ED17E3'><dt id='DE28ED17E3'><span id='DE28ED17E3'></span></dt></select></label></b><u id='DE28ED17E3'></u>
          <i id='DE28ED17E3'><strike id='DE28ED17E3'><tt id='DE28ED17E3'><pre id='DE28ED17E3'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:87881
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news
          Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Orangutan used medicinal plant to treat wound, first time ever seen

          Rakus,aSumatranorangutan,usedthejuiceandleavesofamedicinalplanttotreatawoundonhisface.CourtesyArmasW